Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Safety and Tolerability Profile The safety profile of tirzepatide across clinical trials has been generally consistent with other incretin-based therapies
Focus extra attention on areas with fine lines, crow's feet , or other aging concerns
Key facts Apotex authorization: May 1, 2026 Expected launch: within weeks, per Apotex VP Catherine Thomas Other reviews: seven additional generic semaglutide submissions under Health Canada review This article is for informational purposes only and does not constitute medical advice
AU, arbitrary unit
US$ 22.61
US$ 29.75
US$ 29.74
US$ 22.10
US$ 24.84
